Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iradyn is an intra-articular medical device (filler) composed of polymerized polynucleotides (PDRN), specifically developed for the treatment of knee osteoarthritis. It functions as a viscosupplement, leveraging the hydrophilic and polyanionic properties of the polynucleotide chains to bind water molecules, thereby providing a moisturizing and lubricant effect within the joint. This physical action restores the viscoelasticity of the synovial fluid, reduces mechanical stress, and decreases friction, which results in significant relief of pain and improved joint mobility. Upon enzymatic degradation, the product releases nucleotides into the synovial cavity, which maintain the moisturizing effect and may interact with cellular receptors to promote tissue repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Iradyn.